Table 1 Baseline characteristics of the HIV group and the comparison group
Variable | HIV Patients (n = 1,115) | Control (n = 4,460) | |
|---|---|---|---|
No. (%) | No. (%) | P-value | |
Age | 1 | ||
≦24 | 137 (12.3) | 548 (12.3) | |
25 – 44 | 626 (56.1) | 2,504 (56.1) | |
45 – 64 | 202 (18.1) | 808 (18.1) | |
≧65 | 150 (13.5) | 600 (13.5) | |
Gender | 1 | ||
Male | 836 (75) | 3,344 (75) | |
Female | 279 (25) | 1,116 (25) | |
Monthly income | <0.001 | ||
NTD 0 ~ 17280 | 502 (45) | 1,355 (30.4) | |
NTD 17281 ~ 28800 | 399 (35.8) | 1,624 (36.4) | |
NTD ≥28801 | 279 (19.2) | 1481 (33.2) | |
Urbanization level | <0.001 | ||
1 | 355 (31.8) | 1,291 (29) | |
2 | 313 (28.1) | 1,412 (31.7) | |
3 | 210 (18.8) | 891 (20) | |
4 | 139 (12.5) | 538 (12.1) | |
5 | 22 (2) | 78 (1.8) | |
6 | 35 (3.1) | 126 (2.8) | |
7 | 41 (3.7) | 124 (2.8) | |
Modified Charlson score | <0.001 | ||
0 | 29 (2.6) | 1,644 (36.8) | |
1-5 | 1011 (90.7) | 2638 (59.2) | |
≧6 | 75 (6.7) | 184 (4.1) | |
Mean follow-up time (months) | 55.53 | 56.12 | |
SD | 38.70 | 36.96 | |
Q1 | 26.73 | 26.9 | |
Q3 | 76.98 | 73.73 | |
Cancer | 104 (9.3) | 119 (2.7) | <0.001 |